臨床分子診断の世界中核市場（2023年版）：技術別（ISH、PCR、シーケンス、その他）、用途別（感染症・血液スクリーニング、遺伝子検査、がんスクリーニング、その他）、地域別、国別の分析：市場インサイトと予測（2019-2029年）

Global Core Clinical Molecular Diagnostics Market (2023 Edition): Analysis By Technology (ISH, PCR, Sequencing, Others), By Application (Infectious Disease and Blood Screening, Genetic Testing, Cancer Screening, Others), By Region, By Country: Market Insights and Forecast (2019-2029)

エグゼクティブ・サマリー Azoth Analytics社は、この調査レポート「世界の中核的臨床分子診断薬市場（2023年版）」を出版し、世界の中核的臨床分子診断薬産業を技術別（In situハイブリダイゼーション、ポ... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Azoth Analytics アーゾスアナリティクス	2023年10月1日	US$2,450 シングルユーザライセンスライセンス・価格情報注文方法はこちら	220	英語

サマリー

エグゼクティブ・サマリー

Azoth Analytics社は、この調査レポート「世界の中核的臨床分子診断薬市場（2023年版）」を出版し、世界の中核的臨床分子診断薬産業を技術別（In situハイブリダイゼーション、ポリメラーゼ連鎖反応、シークエンシング、その他）と用途別（感染症・血液スクリーニング、遺伝子検査、癌スクリーニング、その他用途）に市場細分化し、過去期間の2019-2022年、推定期間の2023年、予測期間の2024-2029年について詳細に分析しています。

調査レポートは、地域（米州、欧州、APAC、中東アフリカ）と11カ国（米国、カナダ、英国、ドイツ、イタリア、フランス、スペイン、中国、インド、日本、オーストラリア）の詳細な分析をカバーしている。さらに、この調査レポートは、市場規模、年間成長率と潜在力分析、市場プレイヤーの競争調査、投資機会、需要予測などのデータを提示しています。また、市場成長指標、阻害要因、需給リスク、その他の重要統計、市場の進化に関連する現在および将来の市場動向の完全評価も行っています。

予測期間である2024年から2029年にかけて、世界の中核的臨床分子診断市場はCAGR 10.7%で成長すると予測されます。コア臨床分子診断の世界市場は、2022年の49億米ドルから2029年末までに110億4,000万米ドルを創出すると予測される。

臨床分子診断は、感染症、癌、血液病理学、臨床化学、臨床遺伝学を含む幅広いアプリケーションを包含する急拡大市場である。慢性疾患の有病率の増加と、疾病の早期発見のための高度な診断ソリューションに対する需要の高まりが、市場成長の原動力となっている。

さらに、個別化治療や消費者直接遺伝子検査に対する意識の高まりも市場の成長を支えている。

さらに、感染症の世界的な流行の増加が臨床分子診断ソリューションの需要に大きく寄与しており、ポリメラーゼ連鎖反応（PCR）検査がCOVID-19を検出する主要な方法として浮上している。ポリメラーゼ連鎖反応（PCR）検査の応用は、特に核酸ベースの方法論において、感染症の分子診断分野の強化に重要な役割を果たしている。その結果、この特定分野は臨床分子診断薬市場の中核をなす最も顕著な分野の一つとして浮上している。

レポートの範囲

- このレポートは臨床分子診断の中核市場を金額（10億米ドル）別に分析しています。

- 2019-2022年の過去期間、2023年の推定期間、2024-2029年の予測期間における中核的臨床分子診断薬市場の分析を掲載しています。

- 中核的臨床分子診断薬市場を用途別（感染症・血液スクリーニング、遺伝子検査、癌スクリーニングその他の用途）に分析しています。

- コア臨床分子診断市場を技術別（in situハイブリダイゼーション、ポリメラーゼ連鎖反応、シークエンシング、その他の技術）に分析しています。

- 本レポートの主要な洞察は、SWOTおよびポーターのファイブフォース分析の枠組みを通して提示されています。また、市場の魅力を地域別、用途別、技術別に紹介しています。

- また、業界の主な機会、動向、促進要因、課題についても分析しています。

- 本レポートでは、競合の動向、戦略、M&A、新製品開発などを追跡しています。本レポートで分析している企業は、Merck Group (SigmaAldrich Co., LLC)、F. Hoffmann-La Roche AG、Agilent technologies、PerkinElmer Inc.、Abbott Laboratories、QIAGEN、Thermo Fisher Scientific、Becton, Dickinson and Company、Hologic, Inc.、Danaher Corporationなどです。

ページTOPに戻る

1. Market Background

1.1 Scope and Product Outlook

1.2 Executive Summary

1.3 Research Methodology

2. Strategic Recommendations

2.1 Integration of AI and Data Analytics to deliver highly accurate and rapid results

2.2 Partnerships with Academic Institutes

3. Global Core Clinical Molecular Diagnostics Market: Historic and Forecast (2019-2029)

3.1 Age-standardised cancer incidence rate, 2020*

3.2 SARS-Cov-2 Tests: Volumes 2020

3.3 Molecular diagnostics undergoing Clinical trials

3.4 Global Core Clinical Molecular Diagnostics Market: Dashboard

3.5 Global Core Clinical Molecular Diagnostics Market: Market Value Assessment, 2019-2029 (USD Billion)

3.6 Impact of COVID-19 on the Global Core Clinical Molecular Diagnostics Market

3.7 Global Core Clinical Molecular Diagnostics Market Segmentation: By Application

3.7.1 Global Core Clinical Molecular Diagnostics Market, By Application Overview

3.7.2 Global Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)

3.7.3 Global Core Clinical Molecular Diagnostics Market Size, By Genetic Testing, By Value, 2019H-2029F (USD Billion & CAGR)

3.7.4 Global Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)

3.7.5 Global Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)

3.8 Global Core Clinical Molecular Diagnostics Market Segmentation: By Technology

3.8.1 Global Core Clinical Molecular Diagnostics Market, By Technology Overview

3.8.2 Global Core Clinical Molecular Diagnostics Market Size, By In situ Hybridisation, By Value, 2019H-2029F (USD Billion & CAGR)

3.8.3 Global Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)

3.8.4 Global Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)

3.8.5 Global Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)

4. Global Core Clinical Molecular Diagnostics Market, Region Analysis

4.1 Regional Coverage of the Study

5. Americas Core Clinical Molecular Diagnostics Market: Historic and Forecast (2019-2029)

5.1 Americas Core Clinical Molecular Diagnostics Market: Snapshot

5.2 Americas Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

5.3 Americas Core Clinical Molecular Diagnostics Market: Key Factors

5.4 Americas Core Clinical Molecular Diagnostics Market Segmentation: By Application

5.4.1 Americas Core Clinical Molecular Diagnostics Market, By Application Overview

5.4.2 Americas Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)

5.4.3 Americas Core Clinical Molecular Diagnostics Market Size, By Genetic Testing, By Value, 2019H-2029F (USD Billion & CAGR)

5.4.4 Americas Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)

5.4.5 Americas Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)

5.5 Americas Core Clinical Molecular Diagnostics Market Segmentation: By Technology

5.5.1 Americas Core Clinical Molecular Diagnostics Market, By Technology Overview

5.5.2 Americas Core Clinical Molecular Diagnostics Market Size, By In situ Hybridisation, By Value, 2019H-2029F (USD Billion & CAGR)

5.5.3 Americas Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)

5.5.4 Americas Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)

5.5.5 Americas Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)

5.6 Americas Core Clinical Molecular Diagnostics Market Segmentation: By Country

5.6.1 United States Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

5.6.1.1 United States Core Clinical Molecular Diagnostics Market, By Application

5.6.1.2 United States Core Clinical Molecular Diagnostics Market, By Technology

5.6.2 Canada Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

5.6.2.1 Canada Core Clinical Molecular Diagnostics Market, By Application

5.6.2.2 Canada Core Clinical Molecular Diagnostics Market, By Technology

5.6.3 Rest of Americas Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

5.6.3.1 Rest of Americas Core Clinical Molecular Diagnostics Market, By Application

5.6.3.2 Rest of Americas Core Clinical Molecular Diagnostics Market, By Technology

6. Europe Core Clinical Molecular Diagnostics Market: Historic and Forecast (2019-2029)

6.1 Europe Core Clinical Molecular Diagnostics Market: Snapshot

6.2 Europe Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

6.3 Europe Core Clinical Molecular Diagnostics Market: Key Factors

6.4 Europe Core Clinical Molecular Diagnostics Market Segmentation: By Application

6.4.1 Europe Core Clinical Molecular Diagnostics Market, By Application Overview

6.4.2 Europe Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)

6.4.3 Europe Core Clinical Molecular Diagnostics Market Size, By Genetic Testing, By Value, 2019H-2029F (USD Billion & CAGR)

6.4.4 Europe Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)

6.4.5 Europe Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)

6.5 Europe Core Clinical Molecular Diagnostics Market Segmentation: By Technology

6.5.1 Europe Core Clinical Molecular Diagnostics Market, By Technology Overview

6.5.2 Europe Core Clinical Molecular Diagnostics Market Size, By In situ Hybridisation, By Value, 2019H-2029F (USD Billion & CAGR)

6.5.3 Europe Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)

6.5.4 Europe Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)

6.5.5 Europe Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)

6.6 Europe Core Clinical Molecular Diagnostics Market Segmentation: By Country

6.6.1 France Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

6.6.1.1 France Core Clinical Molecular Diagnostics Market, By Application

6.6.1.2 France Core Clinical Molecular Diagnostics Market, By Technology

6.6.2 United Kingdom Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

6.6.2.1 United Kingdom Core Clinical Molecular Diagnostics Market, By Application

6.6.2.2 United Kingdom Core Clinical Molecular Diagnostics Market, By Technology

6.6.2 Italy Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

6.6.2.1 Italy Core Clinical Molecular Diagnostics Market, By Application

6.6.2.2 Italy Core Clinical Molecular Diagnostics Market, By Technology

6.6.3 Spain Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

6.6.3.1 Spain Core Clinical Molecular Diagnostics Market, By Application

6.6.3.2 Spain Core Clinical Molecular Diagnostics Market, By Technology

6.6.4 Germany Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

6.6.4.1 Germany Core Clinical Molecular Diagnostics Market, By Application

6.6.4.2 Germany Core Clinical Molecular Diagnostics Market, By Technology

6.6.5 Rest of Europe Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

6.6.5.1 Rest of Europe Core Clinical Molecular Diagnostics Market, By Application

6.6.5.2 Rest of Europe Core Clinical Molecular Diagnostics Market, By Technology

7. Asia-Pacific Core Clinical Molecular Diagnostics Market: Historic and Forecast (2019-2029)

7.1 Asia-Pacific Core Clinical Molecular Diagnostics Market: Snapshot

7.2 Asia-Pacific Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

7.3 Asia-Pacific Core Clinical Molecular Diagnostics Market: Key Factors

7.4 Asia-Pacific Core Clinical Molecular Diagnostics Market Segmentation: By Application

7.4.1 Asia-Pacific Core Clinical Molecular Diagnostics Market, By Application Overview

7.4.2 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)

7.4.3 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Genetic Testing, By Value, 2019H-2029F (USD Billion & CAGR)

7.4.4 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)

7.4.5 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)

7.5 Asia-Pacific Core Clinical Molecular Diagnostics Market Segmentation: By Technology

7.5.1 Asia-Pacific Core Clinical Molecular Diagnostics Market, By Technology Overview

7.5.2 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By In situ Hybridisation, By Value, 2019H-2029F (USD Billion & CAGR)

7.5.3 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)

7.5.4 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)

7.5.5 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)

7.6 Asia-Pacific Core Clinical Molecular Diagnostics Market Segmentation: By Country

7.6.1 China Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

7.6.1.1 China Core Clinical Molecular Diagnostics Market, By Application

7.6.1.2 China Core Clinical Molecular Diagnostics Market, By Technology

7.6.2 Japan Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

7.6.2.1 Japan Core Clinical Molecular Diagnostics Market, By Application

7.6.2.2 Japan Core Clinical Molecular Diagnostics Market, By Technology

7.6.3 India Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

7.6.3.1 India Core Clinical Molecular Diagnostics Market, By Application

7.6.3.2 India Core Clinical Molecular Diagnostics Market, By Technology

7.6.4 Australia Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

7.6.4.1 Australia Core Clinical Molecular Diagnostics Market, By Application

7.6.4.2 Australia Core Clinical Molecular Diagnostics Market, By Technology

7.6.5 Rest of Asia-Pacific Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

7.6.5.1 Rest of Asia-Pacific Core Clinical Molecular Diagnostics Market, By Application

7.6.5.2 Rest of Asia-Pacific Core Clinical Molecular Diagnostics Market, By Technology

8. Middle-East & Africa Core Clinical Molecular Diagnostics Market: Historic and Forecast (2019-2029)

8.1 Middle-East & Africa Core Clinical Molecular Diagnostics Market: Snapshot

8.2 Middle-East & Africa Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

8.3 Middle-East & Africa Core Clinical Molecular Diagnostics Market: Key Factors

8.4 Middle-East & Africa Core Clinical Molecular Diagnostics Market Segmentation: By Application

8.4.1 Middle-East & Africa Core Clinical Molecular Diagnostics Market, By Application Overview

8.4.2 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)

8.4.3 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Genetic Testing, By Value, 2019H-2029F (USD Billion & CAGR)

8.4.4 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)

8.4.5 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)

8.5.5 Middle-East & Africa Core Clinical Molecular Diagnostics Market Segmentation: By Technology

8.5.1 Middle-East & Africa Core Clinical Molecular Diagnostics Market, By Technology Overview

8.5.2 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By In situ Hybridisation, By Value, 2019H-2029F (USD Billion & CAGR)

8.5.3 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)

8.5.4 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)

8.5.5 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)

9. Market Dynamics

9.1 Impact Assessment of Market Dynamics on Global Core Clinical Molecular Diagnostics Market

9.2 Drivers

9.3 Restraints

9.4 Trends

10. Porter’s Five Forces Analysis

10.1 Porter’s Five Forces Model

11. Competitive Positioning

11.1 Companies’ Product Positioning

11.2 Market Position Matrix

11.3 Market Share Analysis of Core Clinical Molecular Diagnostics Market

11.4 Company Profiles

11.4.1 Merck Group (SigmaAldrich Co., LLC)

11.4.2 F. Hoffmann-La Roche AG

11.4.3 Agilent technologies

11.4.4 PerkinElmer Inc.

11.4.5 Abbott Laboratories

11.4.6 QIAGEN

11.4.7 Thermo Fisher Scientific

11.4.8 Becton, Dickinson and Company

11.4.9 Hologic, Inc.

11.4.10 Danaher Corporation

ページTOPに戻る

Table of Contents

Summary

Executive Summary

Azoth Analytics has released a research report titled “Global Core Clinical Molecular Diagnostics Market (2023 Edition)” which provides a complete analysis of the Global Core Clinical Molecular Diagnostics industry in terms of market segmentation By Technology (In situ hybridization, Polymerase Chain Reaction, Sequencing, Others) and By Application (Infectious Disease and Blood Screening, Genetic Testing, Cancer Screening, Other Applications) for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.

The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 11 countries (United States, Canada, United Kingdom, Germany, Italy, France, Spain, China, India, Japan, Australia). Additionally, the research report presents data including market size, yearly growth and potential analysis, the competitive study of market players, investment opportunities and demand forecast. The research study also assesses market growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market's evolution.

During the forecast period, 2024-2029, the Global Core Clinical Molecular Diagnostics market is expected to grow at a CAGR of 10.7%. The Global Core Clinical Molecular Diagnostics Market is expected to generate USD 11.04 billion by the end of 2029, up from USD 4.9 Billion in 2022.

Clinical Molecular diagnostics is a rapidly expanding market that encompasses a wide range of applications, including infectious illnesses, cancer, hematopathology, clinical chemistry, and clinical genetics. The increasing prevalence of chronic diseases coupled with the growing demand for advanced diagnostic solutions for early disease detection are driving the market growth.

Additionally, the increasing awareness of personalized treatment and direct-to-consumer genetic testing is also supporting the market growth.

Moreover, the rising global prevalence of infectious diseases has significantly contributed to the demand for clinical molecular diagnostics solutions, wherein polymerase chain reaction (PCR) testing has emerged as the primary method for detecting COVID-19. The application of polymerase chain reaction (PCR) testing has played a significant role in enhancing the field of molecular diagnostics for infectious diseases, specifically in nucleic acid-based methodologies. As a result, this particular segment has emerged as one of the most prominent segments within the core clinical molecular diagnostics market.

Scope of the Report:

• The report analyses the Core Clinical Molecular Diagnostics Market by Value (USD Billion).

• The report presents the analysis of Core Clinical Molecular Diagnostics Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.

• The report analyses the Core Clinical Molecular Diagnostics Market by Application (Infectious disease and blood screening, Genetic testing, Cancer Screening Other Applications).

• The report analyses the Core Clinical Molecular Diagnostics Market by Technology (In situ hybridization, Polymerase Chain Reaction, Sequencing, Other Technologies).

• The key insights of the report have been presented through the frameworks of SWOT and Porter’s Five Forces Analysis. Also, the attractiveness of the market has been presented by Region, by Application & by Technologies.

• Also, the major opportunities, trends, drivers, and challenges of the industry have been analyzed in the report.

• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Merck Group (SigmaAldrich Co., LLC), F. Hoffmann-La Roche AG, Agilent technologies, PerkinElmer Inc., Abbott Laboratories, QIAGEN, Thermo Fisher Scientific, Becton, Dickinson and Company, Hologic, Inc., Danaher Corporation.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

Azoth Analytics社の医療・製薬分野での最新刊レポート

本レポートと同じKEY WORD（blood）の最新刊レポート

よくあるご質問

Azoth Analytics社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療）の最新刊レポート

Azoth Analytics社の医療・製薬分野での最新刊レポート

本レポートと同じKEY WORD（blood）の最新刊レポート

よくあるご質問

Azoth Analytics社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?